Sort by
Refine Your Search
-
to present the results, and interact with other researchers to develop new directions that will aid the OSU Center for Cosmology and AstroParticle Physics (CCAPP, https://ccapp.osu.edu ). CCAPP Fellow
-
antimicrobial pharmacology, antimicrobial resistance, or host-pathogen interactions Experience with bioinformatics, statistical analysis, or clinical/translational research Additional Information: This position
-
approaches to clarify the cell-cell interaction of neural cells with metastatic breast cancer cells in brain and cerebral organoids. Prepare figures, manuscripts, abstracts, and grant submission materials
-
. The successful candidate will contribute to multidisciplinary research focused on tumor immunology, immunometabolism, host–microbiome interactions, and translational cancer biology using cutting-edge metabolite
-
societal contexts. Through advanced computational methods and collaboration, HELM addresses global challenges by blending eco-social health determinants, human-natural system interactions, and convergence
-
for studying protein-protein interactions, cell culture, and use of advanced microscopy and morphometric techniques. Experience of working with obligatory intracellular bacteria is desirable. Laboratory mice
-
Qualifications Ability to interact in a highly multidisciplinary environment; experience with cellular biology, molecular biology, quantitative fluorescence microscopy, live-cell imaging, and flow cytometry
-
of electrical stimulation at both the peripheral and central levels of the auditory system in adult and pediatric participants, including cochlear implant (CI) users, and the interaction between auditory
-
metastasis. Adopt optogenetic and chemogenetic approaches to clarify the cell-cell interaction of neural cells with metastatic breast cancer cells in brain and cerebral organoids. Prepare figures, manuscripts
-
antibody–antigen interactions in cancer and viral diseases, with the goal of advancing therapeutic and vaccine design. The successful candidate will lead structure-based studies of glycoproteins, antibodies